These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9030968

  • 1. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method.
    Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z.
    Horm Res; 1997; 47(2):54-61. PubMed ID: 9030968
    [Abstract] [Full Text] [Related]

  • 2. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height.
    Lazar L, Kauli R, Pertzelan A, Phillip M.
    J Clin Endocrinol Metab; 2002 May; 87(5):2090-4. PubMed ID: 11994346
    [Abstract] [Full Text] [Related]

  • 3. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [Abstract] [Full Text] [Related]

  • 4. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty.
    Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, Chaussain JL.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1973-8. PubMed ID: 10372696
    [Abstract] [Full Text] [Related]

  • 5. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.
    Pucarelli I, Segni M, Ortore M, Arcadi E, Pasquino AM.
    J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1005-10. PubMed ID: 14513877
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty.
    Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, Borrelli P, Crisafulli G, Wasniewska M, De Luca F.
    Eur J Endocrinol; 1999 Aug; 141(2):140-4. PubMed ID: 10427157
    [Abstract] [Full Text] [Related]

  • 7. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R.
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
    [Abstract] [Full Text] [Related]

  • 8. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty.
    Tung YC, Lee JS, Tsai WY, Hsiao PH.
    J Formos Med Assoc; 2007 Oct; 106(10):826-31. PubMed ID: 17964961
    [Abstract] [Full Text] [Related]

  • 9. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R, Soros A, Jakubowicz S.
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [Abstract] [Full Text] [Related]

  • 10. Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.
    Liang Y, Wei H, Li J, Hou L, Zhang J, Wu W, Ying Y, Luo X.
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):839-46. PubMed ID: 25719299
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of central precocious puberty with Gonadotropin-Releasing Hormone agonist (triptorelin) in girls: breast development, skeletal maturation, height and weight evolution during and after treatment].
    Messaaoui A, Massa G, Tenoutasse S, Heinrichs C.
    Rev Med Brux; 2005 Feb; 26(1):27-32. PubMed ID: 15816337
    [Abstract] [Full Text] [Related]

  • 12. [Triptorelin therapy in girls with central precocious puberty increases body mass index].
    Martín Díaz MJ, Soriano Guillén L, Muñoz Calvo MT, Pozo Román J, Argente Oliver J.
    An Pediatr (Barc); 2006 Nov; 65(5):428-33. PubMed ID: 17184602
    [Abstract] [Full Text] [Related]

  • 13. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
    Brito VN, Latronico AC, Cukier P, Teles MG, Silveira LF, Arnhold IJ, Mendonca BB.
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2662-9. PubMed ID: 18460564
    [Abstract] [Full Text] [Related]

  • 14. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M, Di Nardo R.
    J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
    [Abstract] [Full Text] [Related]

  • 15. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
    Bajpai A, Sharma J, Kabra M, Gupta AK, Menon PS.
    Indian Pediatr; 2002 Jul; 39(7):633-9. PubMed ID: 12147888
    [Abstract] [Full Text] [Related]

  • 16. Idiopathic precocious puberty versus puberty in adopted children; auxological response to gonadotrophin-releasing hormone agonist treatment and final height.
    Kempers MJ, Otten BJ.
    Eur J Endocrinol; 2002 Nov; 147(5):609-16. PubMed ID: 12444892
    [Abstract] [Full Text] [Related]

  • 17. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
    Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G.
    Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331
    [Abstract] [Full Text] [Related]

  • 18. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [Abstract] [Full Text] [Related]

  • 19. [Improvement of expected and final height in girls with central precocious puberty treated with gonadotropin releasing hormone analogues].
    Gómez F, Picó AM, Vargas F, Mauri M.
    Med Clin (Barc); 1996 Nov 23; 107(18):681-4. PubMed ID: 9082075
    [Abstract] [Full Text] [Related]

  • 20. End results in central precocious puberty with GnRH analog treatment: the data of the Italian Study Group for Physiopathology of Puberty.
    Antoniazzi F, Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Borrelli P, Osio D, Mengarda F, De Luca F, Tatò L.
    J Pediatr Endocrinol Metab; 2000 Jul 23; 13 Suppl 1():773-80. PubMed ID: 10969920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.